The purpose of this study is to measure the safety and tolerability of TD 4208, an
investigational drug being developed to treat people with moderate to very severe COPD,
compared to tiotropium.
- Subject is a male or female subject 40 years of age or older
- Females who are pregnant, lactating, breast-feeding or planning to become pregnant
during the study